SCHEMBL13065733

SCHEMBL13065733

COc1cccc(-c2c(C(=O)O)c3nc4ccccc4oc-3c(O)c2=O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.53
MAPT P10636 6/20 0.53
HPGD P15428 5/20 0.53
KMT2A Q03164 4/20 0.53
CYP3A4 P08684 4/20 0.53
TSHR P16473 3/20 0.53
MEN1 O00255 3/20 0.53
TDP1 Q9NUW8 3/20 0.53
TP53 P04637 2/20 0.53
CYP2D6 P10635 2/20 0.53
CYP2C9 P11712 2/20 0.53
CYP2C19 P33261 2/20 0.53
ALOX12 P18054 1/20 0.53
MAPK1 P28482 1/20 0.53
SMN1; SMN2 Q16637 4/20 0.46
CSNK2A2 P19784 1/20 0.46
CSNK2B P67870 1/20 0.46
CSNK2A1 P68400 1/20 0.46
GPR35 Q9HC97 2/20 0.44
ALDH1A1 P00352 5/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13065742 0.90 KDM4E (0.47) KDM4EMAPTHPGDKMT2ACYP3A4
SCHEMBL13065729 0.89 KDM4E (0.51) KDM4EMAPTHPGDKMT2ACYP3A4
SCHEMBL13065594 0.87 MAPT (0.44) KDM4EMAPTHPGDKMT2ACYP3A4
SCHEMBL13065731 0.86 DHODH (0.47) KDM4EMAPTHPGDKMT2ACYP3A4
SCHEMBL13065603 0.85 MAPT (0.42) KDM4EMAPTHPGDKMT2ACYP3A4
SCHEMBL13065735 0.81 LMNA (0.48) KDM4EMAPTHPGDKMT2ACYP3A4
SCHEMBL13065744 0.80 ABCG2 (0.48) KDM4EMAPTHPGDKMT2ACYP3A4
SCHEMBL13065738 0.80 HPGD (0.42) KDM4EMAPTHPGDKMT2ACYP3A4
SCHEMBL13065732 0.79 MAPK14 (0.45) KDM4EMAPTHPGDKMT2ACYP3A4
SCHEMBL16784744 0.79 PDE10A (0.40) KDM4EMAPTHPGDKMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9052324-B2 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. (US) 2015-06-09 US disclosed
US-20120322717-A9 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. 2012-12-20 US disclosed
US-20100298200-A1 Compounds and assays for controlling Wnt activity LIU DAKAI 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322717-A9 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 KDM4E 4062/4885MAPT 3092/4885HPGD 3218/4885
US-20100298200-A1 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 KDM4E 4062/4885MAPT 3092/4885HPGD 3218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.